Skip to main content

furosemide

Generic: FUROSEMIDE·Brand: Disal, FUROSCIX, FUROSEMIDE, Furoscix, LASIX, LASIX ONYU, Lasix, Salix - substance

furosemide: 7 clinical trials tracked.

furosemide evidence translation

What we can confirm

7 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about furosemide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 5 study sponsors
Clinical Trials (7)

Bumetanide vs. Furosemide for Adults Hospitalized With Cirrhosis: the BUFF Trial

NCT06941415·Phase 3·JNJ
Recruiting

Primary endpoint: Percent change in weight

InterventionalRandomizedopen500 targetStarted 2026-06Completion 2029-031 site · United StatesStacy Johnson

A Two-Part Clinical Study to Evaluate the Effect of Multiple Doses of MK-2828 on Rosuvastatin (Part 1) and Furosemide (Part 2) in Healthy Participants

NCT07431866·Phase 1
Completed

Primary endpoint: Area Under the Concentration-Time Curve from Time 0 Extrapolated to Infinity (AUC0-inf) of Rosuvastatin

Interventionalopen41 enrolledStarted 2026-03Completion 2026-061 site · United StatesMerck Sharp & Dohme LLC

Gator SCALES-WHF: SubCutaneous Administration of Lasix to Eliminate Symptoms of Worsening Heart Failure

NCT06979726·Phase 4
Recruiting

Primary endpoint: Safety of Lasix ONYU Use

Interventionalopen100 targetStarted 2025-11Completion 2026-121 site · United StatesUniversity of Florida

"Comparison of Furosemide Versus Albumin Plus Furosemide in Increasing Urine Output in Critically Ill Patients: A Double-Blind Randomized Clinical Trial"

Recruiting

Primary endpoint: Urine output at 2 hours

InterventionalRandomizedquadruple56 targetStarted 2025-06Completion 2026-101 site · MexicoJose J Zaragoza, MD MSc

A Modular Phase I, Open-label Study to Assess the Safety, Pharmacokinetics, and Drug Interaction Potential and Relative Bioavailability of Saruparib in Patients With Advanced Solid Malignancies

NCT06899061·Phase 1·AZN
Active, not recruiting

Primary endpoint: Module 1: Area under plasma concentration-time curve from zero extrapolated to infinity (AUCinf) of digoxin, furosemide, metformin and rosuvastatin when dosed alone and in combination with saruparib

InterventionalRandomizedopen41 enrolledStarted 2025-03Completion 2028-054 sites · Bulgaria, Moldova, RomaniaAstraZeneca

An Open-label, Single-dose, Randomized, Two-way, Two-period Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously Versus the Same Dose (80 mg) Administered Intravenously in Subjects With Chronic Heart Failure

NCT04384653·Phase 1/Phase 2·IPIX
Completed

Primary endpoint: AUC Last

InterventionalRandomizedopen20 enrolledStarted 2020-10Completion 2021-061 site · United StatesSQ Innovation, Inc.

Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants

Recruiting

Primary endpoint: M/P ratio

Observational1,600 targetStarted 2018-10Completion 2027-0722 sites · Canada, United StatesDuke University